|
Atomistry » Arsenic » PDB 6j05-6wrb » 6nna | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Atomistry » Arsenic » PDB 6j05-6wrb » 6nna » |
Arsenic in PDB 6nna: Human Fatty Acid Synthase Psi/Kr Tri-Domain with Nadph and Compound 22Enzymatic activity of Human Fatty Acid Synthase Psi/Kr Tri-Domain with Nadph and Compound 22
All present enzymatic activity of Human Fatty Acid Synthase Psi/Kr Tri-Domain with Nadph and Compound 22:
1.1.1.100; 1.3.1.39; 2.3.1.38; 2.3.1.39; 2.3.1.41; 2.3.1.85; 4.2.1.59; Protein crystallography data
The structure of Human Fatty Acid Synthase Psi/Kr Tri-Domain with Nadph and Compound 22, PDB code: 6nna
was solved by
A.V.Toms,
M.W.Martin,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Arsenic Binding Sites:
The binding sites of Arsenic atom in the Human Fatty Acid Synthase Psi/Kr Tri-Domain with Nadph and Compound 22
(pdb code 6nna). This binding sites where shown within
5.0 Angstroms radius around Arsenic atom.
In total 2 binding sites of Arsenic where determined in the Human Fatty Acid Synthase Psi/Kr Tri-Domain with Nadph and Compound 22, PDB code: 6nna: Jump to Arsenic binding site number: 1; 2; Arsenic binding site 1 out of 2 in 6nnaGo back to Arsenic Binding Sites List in 6nna
Arsenic binding site 1 out
of 2 in the Human Fatty Acid Synthase Psi/Kr Tri-Domain with Nadph and Compound 22
Mono view Stereo pair view
Arsenic binding site 2 out of 2 in 6nnaGo back to Arsenic Binding Sites List in 6nna
Arsenic binding site 2 out
of 2 in the Human Fatty Acid Synthase Psi/Kr Tri-Domain with Nadph and Compound 22
Mono view Stereo pair view
Reference:
M.W.Martin,
D.R.Lancia Jr.,
H.Li,
S.E.R.Schiller,
A.V.Toms,
Z.Wang,
K.W.Bair,
J.Castro,
S.Fessler,
D.Gotur,
S.E.Hubbs,
G.S.Kauffman,
M.Kershaw,
G.P.Luke,
C.Mckinnon,
L.Yao,
W.Lu,
D.S.Millan.
Discovery and Optimization of Novel Piperazines As Potent Inhibitors of Fatty Acid Synthase (Fasn). Bioorg. Med. Chem. Lett. V. 29 1001 2019.
Page generated: Wed Jul 10 13:28:21 2024
ISSN: ESSN 1464-3405 PubMed: 30803804 DOI: 10.1016/J.BMCL.2019.02.012 |
Last articlesZn in 9JPJZn in 9JP7 Zn in 9JPK Zn in 9JPL Zn in 9GN6 Zn in 9GN7 Zn in 9GKU Zn in 9GKW Zn in 9GKX Zn in 9GL0 |
© Copyright 2008-2020 by atomistry.com | ||
Home | Site Map | Copyright | Contact us | Privacy |